Search Clinical Trials

Search results for

Neuromuscular Blockade and the effects of Sugammadex

This is a randomized, active comparator-controlled, parallel-group, multi-site, double-blind safety trial of sugammadex (MK-8616) for the reversal of neuromuscular blockade (NMB) induced by rocuronium or…

Supranuclear Palsy and the effects of Intravenously Administered BMS-986168

The Primary objective of the study is to evaluate the efficacy of BIIB092, compared to placebo, as measured by a change from baseline in the…

Exploratory Digital Assessment of Cognition and Function with Alzheimer’s Disease

Exploratory Digital Assessment of Cognition and Function in Healthy Controls and Subjects with Alzheimer's Disease

Open Posterior Spinal Fusion Procedures and the effects of the SA4AG Vaccine

The purposes of the clinical trial are to determine whether the SA4Ag vaccine can prevent postoperative Staphylococcus aureus infections in patients who are undergoing elective…

Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry

The Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) registry is designed to provide important and timely insight into the management of acute stroke patients…

Multiple Sclerosis and the effects of MD1003

The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the disability of patients suffering from progressive multiple sclerosis and…

Multiple Sclerosis and the effects of Ocrelizumab

This study will evaluate the efficacy and safety of ocrelizumab in participants with RRMS who have had a suboptimal response to an adequate course of…

Plegridy Real World Effectiveness and Safety Observational Program

The primary objectives of the study are to determine the incidence of serious adverse events (SAEs) in participants with relapsing forms of multiple sclerosis (MS)…

Multiple Sclerosis and documentation of the drug utilization of Tecfidera (Dimethyl Fumarate)

The primary objective of the study is to determine the incidence, type, and pattern of serious adverse events (SAEs), including but not limited to infections…

ALS and the effects of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA)

AMX0035 is a combination therapy designed to reduce neuronal death through blockade of key cellular death pathways originating in the mitochondria and endoplasmic reticulum (ER).…